Today: February 28, 2017, 1:54 am

Amedisys, Inc. - Strategy and SWOT Report - New Market Research Report

Fast Market Research recommends "Amedisys, Inc. - Strategy and SWOT Report" from MarketLine, now available 2014-08-19 08:28:40
Amedisys, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360deg view of the company.

This Report Features

* Detailed information on Amedisys, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Amedisys, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Amedisys, Inc. including a breakdown and examination of key business segments
* Intelligence on Amedisys, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Amedisys, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..

Report Highlights

Amedisys (or 'the company') is one of the leading home health care and hospice service providers in the US. It operates Medicare-certified home health care centers, Medicare-certified hospice care centers and hospice inpatient units in several US states, the District of Columbia and Puerto Rico. The company is headquartered in Baton Rouge, Los Angeles, and employed about 14,300 people as of March 10, 2014. The company recorded revenues of $1,249.3 million during the financial year ended December 2013 (FY2013), a decrease of 13.3% compared to FY2012. The operating loss of the company was $154.9 million during FY2013, as compared to an operating loss of $108.9 million in FY2012. The net loss was $96.2 million in FY2013, as compared to a net loss of $83.6 million in FY2012.

Reasons to Get this Report

* Gain understanding of Amedisys, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Amedisys, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Amedisys, Inc.'s business structure, strategy and prospects

Report Table of Contents:

Company Snapshot
- Amedisys, Inc.: Company Overview
- Amedisys, Inc.: Overview and Key Facts
-- Amedisys, Inc.: Overview
-- Amedisys, Inc.: Key Facts
- Amedisys, Inc.: Key Employees
- Amedisys, Inc.: Key Employee Biographies
- Amedisys, Inc.: Major Products and Services
- Amedisys, Inc.: Company History
- Amedisys, Inc.: Management Statement
- Amedisys, Inc.: Locations and Subsidiaries
Amedisys, Inc.: Company Analysis
- Amedisys, Inc.: Business Description
- Amedisys, Inc.: SWOT Analysis
-- Amedisys, Inc.: SWOT Overview
-- Amedisys, Inc.: Strengths
-- Amedisys, Inc.: Weaknesses
-- Amedisys, Inc.: Opportunities
-- Amedisys, Inc.: Threats
- Amedisys, Inc.: Corporate Financial Deals Activity
- Amedisys, Inc.: Financial Deals Overview
- Amedisys, Inc.: Targets and Partners
- Amedisys, Inc.: Top Deals 2010 - 2014YTD*
- Amedisys, Inc.: Mergers and Acquisitions
Amedisys, Inc.: Recent Developments
- Amedisys, Inc.: News and Events Summary
- Amedisys, Inc.: Corporate Governance
- Amedisys, Inc.: Financial Performance
- Contact Us
- Methodology
- Definitions
- About Datamonitor

List of Tables

Table 1: Amedisys, Inc.: Key Facts
Table 2: Amedisys, Inc.: Key Employees
Table 4: Amedisys, Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Table 5: Amedisys, Inc.: M&A Average Deal Size - Value (US$m)
Table 6: Amedisys, Inc.: Targets and Partners
Table 7: Amedisys, Inc.: Top Deals 2010 - 2014YTD*
Table 8: Amedisys, Inc.: M&A Volume and Value Trend (2010 - YTD*2014)
Table 9: Amedisys, Inc.: M&A Activity by Geography (2010 - YTD*2014)
Table 10: Amedisys, Inc.: News and Events Summary
Table 11: Amedisys, Inc.: Corporate Governance
Table 12: Amedisys, Inc.: Financial Performance

List of Figures

Figure 1: Amedisys, Inc.: Deal Activity by Deal Type - Volume (2010 - YTD*2014)
Figure 2: Amedisys, Inc.: M&A Average Deal Size - Value (US$m)
Figure 3: Amedisys, Inc.: M&A Volume and Value Trend (2010 - YTD*2014)
Figure 4: Amedisys, Inc.: M&A Activity by Geography (2010 - YTD*2014)

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Press Information

Published by
Bill Thompson

# 815 Words
Related Articles
More From Business
Enstar Group Limited Announces Appointment of New [..]
    HAMILTON, Bermuda, Feb. 27, 2017 (GLOBE NEWSWIRE) -- Enstar Group Limited ("Enstar") (Nasdaq:ESGR) today announced [..]
Microskin Announces Agreement with Nice Pak Products [..]
LONDON and BRISBANE, Australia, February 27, 2017 - Microskin plc (MLSKN:Euronext Paris) announced today that the company has [..]
Novavax Reports Fourth Quarter and Year-End 2016 [..]
GAITHERSBURG, Md., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for [..]
New Analysis of Reverse Trial Shows Medtronic [..]
JACC: HF Study Showcases Economic Value of Earlier Patient Access to Cardiac Resynchronization Therapy DUBLIN - Feb. 27, 2017 [..]
INTL FCStone Inc. Launches World's First Web-Based [..]
NEW YORK, Feb. 27, 2017 (GLOBE NEWSWIRE) -- INTL FCStone Inc. (NASDAQ:INTL), a leader in the development of specialized financial [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.